NRG Oncology Network Group Operations Center

NRG 肿瘤网络集团运营中心

• 批准号: 10609464
• 负责人: NORMAN WOLMARK
• 金额: $ 389.73万
• 依托单位: NRG ONCOLOGY FOUNDATION, INC.
• 依托单位国家: 美国
• 财政年份: 2014
• 资助国家: 美国
• 起止时间: 2014-04-17 至 2025-02-28
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10609464
• 关键词: Address; Adult; Advisory Committees; Biological Specimen Banks; Cancer Patient; Clinical Trials; Collaborations; Data Coordinating Center; Development; Fostering; Goals; Infrastructure; Lead; Leadership; Mentors; Mission; Modeling; Modernization; National Clinical Trials Network; Oncology; Population; Productivity; Research; Site; cohort; experience; improved; member; operation; organizational structure; programs; remote monitoring; statistics; success

NRG Administrative Core Abstract The NRG Oncology (NRG) Administrative Core provides the leadership and infrastructure necessary to support the largest portfolio of clinical trials among the adult groups in the NCI National Clinical Trail Network (NCTN), a membership encompassing over 220 main member sites – including nearly every Lead Academic Participating Site (LAPS) and a robust contribution to the overall management and success of the NCTN. NRG utilizes a highly successful multiple-PI model to provide remarkably capable leadership and scientific oversight, dynamic committee leadership and mentoring, knowledgeable and experienced administrative and operational leadership, and appropriate associated support. NRG, a group formed only four years ago, has leveraged the strengths of its legacy groups to form an integrated, modern clinical trials organization addressing specific populations within the NCTN. It is notable that NRG remained highly productive in all realms even while navigating the merger of the three legacy groups, a testament to the remarkable leadership of NRG and the thoughtful organizational structure put into place. In addition to supporting its own goals, NRG is a highly collaborative member of the NCTN. NRG co-led a number of trials with other groups, championed sixteen studies from other groups, participated in numerous NCI-appointed steering committees, workgroups, and task forces, and led the development of new remote monitoring standards. NRG has the leadership and infrastructure in place to continue to support the clinical trial and membership goals as well as continue to serve as engaged stakeholders in the overall management and success of the NCTN.

NRG管理核心摘要 NRG肿瘤学(NRG)管理核心提供领导和基础设施 有必要支持NCI成人群体中最大的临床试验组合 国家临床试验网络(NCTN)，一个包括220多个主要成员的成员 站点-包括几乎所有领先的学术参与站点(LAPS)和强大的 对NCTN的整体管理和成功作出了贡献。NRG利用了高度的 成功的多重PI模式提供了非常有能力的领导和科学监督， 富有活力的委员会领导和指导、知识渊博和经验丰富的行政管理 和业务领导，以及适当的相关支持。NRG，一个小组只有四个人 几年前，已利用其遗产集团的优势，形成了一个完整的、现代的 针对NCTN内特定人群的临床试验组织。值得注意的是， NRG在所有领域都保持着很高的生产率，即使在三者合并的过程中也是如此 遗产团体，证明了NRG的非凡领导力和深思熟虑的 组织架构到位。除了支持自己的目标外，NRG还是一个高度 NCTN的协作成员。NRG与其他组织共同领导了一些试验， 支持来自其他小组的16项研究，参与了许多NCI任命的 指导委员会、工作组和工作组，并领导开发新的Remote 监测标准。NRG拥有领导层和基础设施，可以继续支持 临床试验和成员目标，以及继续作为利益相关者参与 NCTN的全面管理和成功。